Is the CSL share price dirt cheap and a bargain buy?
Image source: Getty Images
The CSL Ltd (ASX: CSL) share price is having another difficult session on Wednesday.
At the time of writing, the biotechnology giant’s shares are down a further 5% to $168.80.
This follows an even more significant decline on Tuesday in response to a guidance downgrade at its annual general meeting.
In light of today’s move, the company’s shares are now down 40% since the start of the year.
This is astonishing given its reputation as one of the most reliable and highest quality companies that the Australian share market has to offer.
Let’s see if analysts think this is a buying opportunity or whether investors should stay clear of the struggling company for the time being.
